Liver News and Research

RSS

Study shows that drinking green tea before taking supplements may reduce toxicity risk

As high doses of green tea extract supplements for weight loss become more popular, potential liver toxicity becomes a concern. In the last decade, dozens of people have been diagnosed with the condition. However, drinking green tea in the weeks before taking supplements likely reduces risk, according to researchers in Penn State's College of Agricultural Sciences.

5 Feb 2015

Lung cancer surpasses breast cancer as the biggest cancer killer for women in developed countries

A new analysis led by researchers at the American Cancer Society in collaboration with the International Agency for Research on Cancer finds lung cancer has surpassed breast cancer as the leading cause of cancer death in females in developed countries.

5 Feb 2015

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.

5 Feb 2015

Two genetic mutations can interact to reduce risk for heart attack

Researchers have determined that two mutations on a single gene can interact in a way that lowers the carrier's risk for a heart attack.

4 Feb 2015

International community funding can significantly reduce cancer deaths in LMICs by 2030

Increased annual international community funding of US$18 billion globally could save three million lives per year by 2030 and many more in succeeding decades,

3 Feb 2015

Researchers reveal new pathway for inhibiting growth of tumor cells tied to BRCA mutations

Inhibiting the action of a particular enzyme dramatically slows the growth of tumor cells tied to BRCA1 and BRCA2 genetic mutations which, in turn, are closely tied to breast and ovarian cancers, according to researchers at NYU Langone Medical Center.

3 Feb 2015

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

3 Feb 2015

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer.

2 Feb 2015

Study discovers microRNA signatures that could predict prognosis, distant metastasis in colorectal cancer

A new study developed at the Center for Gastrointestinal Cancer Research and the Center for Epigenetics, Cancer Prevention and Cancer Genomics at Baylor Research Institute has discovered unique metastasis-specific microRNA signatures in primary colorectal cancers that could predict prognosis and distant metastasis in colorectal cancer.

31 Jan 2015

Study reveals how the brain can use fatty acids to control liver lipid production

Ways of keeping the heart healthy has widened, with the discovery that the brain can help fight off hardening of the arteries.

31 Jan 2015

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.

31 Jan 2015

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

The farnesoid-X receptor (FXR), also known as the chief regulator of bile acid metabolism, is thought to play a role in some hepatobiliary and gastrointestinal disorders.

30 Jan 2015

Older users of opioids more likely to become victim of homicide, shows study

Older users of opioids such as heroin are 27 times more likely to become a victim of homicide than the general population, a University of Manchester study of almost 200,000 users has found.

30 Jan 2015

Marie Csete appointed president and chief scientist of HMRI

Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.

29 Jan 2015

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment for four strains of viral hepatitis in the United States, based on insights revealed by analysis of Quest’s national testing database.

From Quest Diagnostics 29 Jan 2015

Long-term TDF therapy offers sustained HBV suppression without resistance

Patients with chronic hepatitis B virus infection can achieve sustained viral suppression with long-term tenofovir disoproxil fumarate treatment without developing resistance, shows a 7-year study.

28 Jan 2015

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment for four strains of viral hepatitis in the United States, based on insights revealed by analysis of Quest's national testing database.

From Quest Diagnostics 28 Jan 2015

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

A new range of vitamins and food supplements developed to enhance the health of specific organs has been launched in the UK.

28 Jan 2015

Alcohol drinking pattern influences risk of cirrhosis

Approximately 170,000 people die from alcoholic cirrhosis of the liver in Europe every year. Although alcohol is the most important risk factor, less is known about the significance of different patterns of drinking. Currently scientists believe that cirrhosis is a function of the volume of alcohol consumed irrespective of patterns of drinking. Investigators have now established that alcohol drinking pattern has a significant influence on the risk of cirrhosis and that daily drinking increases that risk compared with drinking less frequently.

27 Jan 2015

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

A study led by the National University of Singapore found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemoresistant cancer stem cells. The findings were first published online in ACS Nano, the official journal of the American Chemical Society, in December 2014.

26 Jan 2015

Liver News and Research

Study shows that drinking green tea before taking supplements may reduce toxicity risk

Lung cancer surpasses breast cancer as the biggest cancer killer for women in developed countries

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Two genetic mutations can interact to reduce risk for heart attack

International community funding can significantly reduce cancer deaths in LMICs by 2030

Researchers reveal new pathway for inhibiting growth of tumor cells tied to BRCA mutations

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Study discovers microRNA signatures that could predict prognosis, distant metastasis in colorectal cancer

Study reveals how the brain can use fatty acids to control liver lipid production

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Older users of opioids more likely to become victim of homicide, shows study

Marie Csete appointed president and chief scientist of HMRI

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

Long-term TDF therapy offers sustained HBV suppression without resistance

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

Alcohol drinking pattern influences risk of cirrhosis

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News